SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Knighty Tin who wrote (64754)7/17/1999 8:01:00 PM
From: Simba  Read Replies (2) of 132070
 
Mike:

MSFT, INTC, CSCO are aggressive invetors the past few years buying stakes in high flying paper and reporting the investment gains. They are kind of like having mini-CMGI's as additions to their product line.

Have you looked at the sales growth or EPS growth based only on what their products generate and not from their venture capital business the past few years ? I guess the analysts rarely talk about real product driven sales growth; or are we buying investment banks in these cases such as a Citigroup ?

In particular CSCO keeps buying companies nearly every week and keeps taking write offs on in-process R&D every quarter. These write-offs are viewed as non-recurring in calculating EPS growth when it is actually a recurring expense for CSCO. CSCO does not have to have a recurring R&D expenditure but keep buying companies periodically for R&D but write it all off as non-recurring. Also obtain lower tax rates in the process.

All accounting gimmicks and FASB seems to allow this on top of the options accounting gimmicks that Buffet talks about.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext